Vitanova Biomedical is an early-stage biotechnology company focused on delivering transformative cancer therapy.
Vitanova Biomedical is an early-stage biotechnology company focused on delivering transformative cancer therapy with the use of Light-Activated Intracellular Acidosis.
The company aims to improve the lives of cancer patients and the professionals who care for them by providing cost-effective and efficacious cancer therapy that eliminates side effects.
It was founded in 2015 by Matt Gdovin and Greg Espenhover in Kerrville, Texas in 2015.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 27, 2020 | Grant | $225K | 1 |
![]() |
— | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
![]() |
Yes | Grant |